YDES Stock Summary and Trading Ideas (YD Bio Limited - | NASDAQ:YDES)

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

What symbol and exchange does YD Bio Limited - shares trade?

YD Bio Limited - trades on the NASDAQ stock market under the symbol YDES.

What is YD Bio Limited - stock price doing today?

As of April 16, 2026, YDES stock price declined to $5.35 with 13,218 million shares trading.

What is YD Bio Limited -'s Beta?

YDES has a beta of 2.65, meaning it tends to be more sensitive to market movements. YDES has a correlation of 0.05 to the broad based SPY ETF.

How much is YD Bio Limited - worth?

YDES has a market cap of $377.29 million. This is considered a Small Cap stock.

What are the top ETFs holding YD Bio Limited -?

The top ETF exchange traded funds that YDES belongs to (by Net Assets): ONEQ.

What are the support and resistance levels for YD Bio Limited - (YDES)?

YDES support price is $4.80 and resistance is $6.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that YDES shares will trade within this expected range on the day.